UA Team Uncovers Promising Lead In Treating Glioblastoma

A team of UA researchers who looked for genetic differences between glioblastoma cells from long- and short-term survivors discovered that those who survived longer had a protein that might be targeted to increase survival in all patients. “I was curious to know how genes are differentially expressed in patients who live longer,” said Dr. Michael Hammer, Co-Director of the UA Cancer Center Genomics Shared Resource and Associate Director of Omics at the BIO5 Institute.

MORE ›

Department of Immunobiology Professor Creates Way To Target Autoimmune Diseases And T Lymphoma

BIO5's Dr. Michael Kuhns, Associate Professor in the Department of Immunobiology in the UA College of Medicine – Tucson, discusses how his research has led to the development of a new strategy for eliminating pathogenic T cells in humans, and how he worked with TLA to invent and license the technology.

MORE ›

Military Hopes 3D Printing Bones Can Help Combat Veterans' Injuries

Dr. John A. Szivek, BIO5 member and Professor of Orthopaedic Surgery at the UA College of Medicine, is working with a five year, $2 million grant from the U.S. Department of Defense, to study how to heal shattered bones, using a combination of 3D printing and adult stem cells. This will help injured combat veterans, cancer patients, and victims of serious injuries.

MORE ›

UA Institutes Work To Build Data Literacy And Transdisciplinary Research

Two new institutes have put the UA on track to become a data science powerhouse at the national level, and leader in promoting data science literacy and transdisciplinary research. Four BIO5 members, including Dr. Nirav Merchant, Data7's Director, have been instrumental in connecting researchers, fostering collaboration, and promoting data science literacy across campus.

MORE ›

A Bold New Strategy For Stopping The Rise of Superbugs

Scientists have pinpointed a molecule that accelerates the evolution of drug-resistant microbes. Now they're trying to find a way to block it. "All steps forward are good, and I think this is a great one," said Dr. Michael Johnson, BIO5 member and Assistant Professor of Immunobiology at the UA College of Medicine—Tucson.